A Newly Identified 191A/C Mutation in the Rv2629 Gene that Was Significantly Associated with Rifampin Resistance in Mycobacterium tuberculosis
- 31 October 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (12) , 4564-4571
- https://doi.org/10.1021/pr070242z
Abstract
In an effort to identify the new resistance factors in rifampin resistant (RIF (r)) Mycobacterium tuberculosis ( M. tb), comparative proteome analysis and gene mutation assays were used to identify the differentially expressed proteins and correlated gene mutations among clinical RIF (r) isolates lacking rpoB mutations, RIF sensitive (RIF (s)) isolates, and the laboratory H37Rv strain. MALDI-TOF-MS revealed nine differentially expressed protein spots. PCR sequencing results showed four genes were mutated. The newly identified 191A/C mutation, in the gene Rv2629, was carried by 111 out of 112 clinical RIF (r) isolates. However, this mutation was absent in H37Rv and RIF (s) isolates. The RIF (s) species Mycobacterium smegmatis displayed RIF resistance only after being transformed with the mutated M. tb Rv2629, while it was not restored by the wild type gene. These results indicate that the 191A/C mutation of the Rv2629 gene may be associated with RIF resistance.Keywords
This publication has 39 references indexed in Scilit:
- Tuberculosis Drug Resistance: A Global ThreatClinical Infectious Diseases, 2003
- Worldwide Incidence of Multidrug‐Resistant TuberculosisThe Journal of Infectious Diseases, 2002
- Structural Mechanism for Rifampicin Inhibition of Bacterial RNA PolymerasePublished by Elsevier ,2001
- Crystal Structure of Thermus aquaticus Core RNA Polymerase at 3.3 Å ResolutionCell, 1999
- Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 updateTubercle and Lung Disease, 1998
- Antimicrobial agent resistance in mycobacteria: molecular genetic insightsClinical Microbiology Reviews, 1995
- Drug-resistant tuberculosis: laboratory issues: World Health Organization recommendationsTubercle and Lung Disease, 1994
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993
- Multidrug-resistant tuberculosis and its controlResearch in Microbiology, 1993
- Susceptibility of Mycobacteria to RifampinAntimicrobial Agents and Chemotherapy, 1972